Vault-13

Bellevue Group AG

ZURICH, V8 · CIK 1674546 · 13F filing filed 2022-08-11

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

Other 13F filers in this group: Bellevue Asset Management AG files a notice

$7.1bn reported value -17.9% vs Q1 2022
172positions
34.7%in top 10
10 new 57 added 82 reduced 15 sold out vs Q1 2022

This report includes the holdings of 3 other managers that share the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 IONIS PHARMACEUTICALS INC COM IONS IONS 9,776,528 $361.9m5.12% 5.12% ReducedShares held: Q3 2021 9.3m, Q4 2021 10.4m, Q1 2022 9.9m, Q2 2022 9.8m -141.5k -141,545 -1.4%
2 ARGENX SE SPONSORED ADR ARGX ARGX 933,803 $349.6m4.94% 4.94% ReducedShares held: Q3 2021 983.9k, Q4 2021 997.0k, Q1 2022 953.2k, Q2 2022 933.8k -19.4k -19,435 -2.0%
3 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 1,176,136 $331.4m4.68% 4.68% ReducedShares held: Q3 2021 1.8m, Q4 2021 1.8m, Q1 2022 1.5m, Q2 2022 1.2m -304.1k -304,117 -20.5%
4 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 2,844,305 $277.3m3.92% 3.92% ReducedShares held: Q3 2021 3.0m, Q4 2021 3.2m, Q1 2022 3.0m, Q2 2022 2.8m -179.1k -179,146 -5.9%
5 MODERNA INC COM MRNA MRNA 1,577,351 $225.3m3.19% 3.19% ReducedShares held: Q3 2021 1.7m, Q4 2021 1.7m, Q1 2022 1.6m, Q2 2022 1.6m -62.0k -61,998 -3.8%
6 INCYTE CORP COM INCY INCY 2,773,377 $210.7m2.98% 2.98% ReducedShares held: Q3 2021 3.0m, Q4 2021 3.0m, Q1 2022 2.8m, Q2 2022 2.8m -74.0k -74,023 -2.6%
7 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 3,349,379 $191.2m2.70% 2.70% ReducedShares held: Q3 2021 3.8m, Q4 2021 3.6m, Q1 2022 3.4m, Q2 2022 3.3m -80.2k -80,240 -2.3%
8 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 909,348 $182.5m2.58% 2.58% AddedShares held: Q3 2021 610.8k, Q4 2021 584.5k, Q1 2022 620.1k, Q2 2022 909.3k +289.3k +289,280 46.6%
9 ABBOTT LABS COM ABT ABT 1,573,807 $171.0m2.42% 2.42% ReducedShares held: Q3 2021 1.4m, Q4 2021 1.7m, Q1 2022 1.6m, Q2 2022 1.6m -49.1k -49,120 -3.0%
10 UNITEDHEALTH GROUP INC COM UNH UNH 302,044 $155.1m2.19% 2.19% ReducedShares held: Q3 2021 338.0k, Q4 2021 312.3k, Q1 2022 305.7k, Q2 2022 302.0k -3.7k -3,657 -1.2%
11 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 1,058,186 $154.3m2.18% 2.18% ReducedShares held: Q3 2021 1.4m, Q4 2021 1.3m, Q1 2022 1.2m, Q2 2022 1.1m -171.4k -171,377 -13.9%
12 BOSTON SCIENTIFIC CORP COM BSX BSX 3,850,171 $143.5m2.03% 2.03% ReducedShares held: Q3 2021 3.0m, Q4 2021 3.0m, Q1 2022 3.9m, Q2 2022 3.9m -63.8k -63,776 -1.6%
13 JAZZ PHARMACEUTICALS PLC SHS USD JAZZ JAZZ 917,907 $143.2m2.02% 2.02% AddedShares held: Q3 2021 769.2k, Q4 2021 886.9k, Q1 2022 755.0k, Q2 2022 917.9k +162.9k +162,926 21.6%
14 AXONICS INC COM AXNX AXNX 2,313,852 $131.1m1.85% 1.85% AddedShares held: Q3 2021 1.6m, Q4 2021 1.9m, Q1 2022 2.0m, Q2 2022 2.3m +264.6k +264,647 12.9%
15 ELEVANCE HEALTH INC COM ELV ELV 208,500 $100.6m1.42% 1.42% ReducedShares held: Q3 2021 475.2k, Q4 2021 455.3k, Q1 2022 411.6k, Q2 2022 208.5k -203.1k -203,137 -49.4%
16 EDWARDS LIFESCIENCES CORP COM EW EW 1,010,627 $96.1m1.36% 1.36% AddedShares held: Q3 2021 870.0k, Q4 2021 921.2k, Q1 2022 912.8k, Q2 2022 1.0m +97.8k +97,842 10.7%
17 SAGE THERAPEUTICS INC COM SAGE SAGE 2,973,178 $96.0m1.36% 1.36% ReducedShares held: Q3 2021 3.2m, Q4 2021 3.2m, Q1 2022 3.1m, Q2 2022 3.0m -79.2k -79,226 -2.6%
18 STRYKER CORPORATION COM SYK SYK 477,634 $95.0m1.34% 1.34% AddedShares held: Q3 2021 422.3k, Q4 2021 421.9k, Q1 2022 440.2k, Q2 2022 477.6k +37.4k +37,409 8.5%
19 DANAHER CORPORATION COM DHR DHR 364,036 $92.3m1.30% 1.30% AddedShares held: Q3 2021 456.7k, Q4 2021 591.8k, Q1 2022 357.1k, Q2 2022 364.0k +7.0k +6,974 1.9%
20 RADIUS HEALTH INC COM NEW RDUS RDUS 8,796,538 $91.2m1.29% 1.29% AddedShares held: Q3 2021 7.8m, Q4 2021 7.8m, Q1 2022 8.3m, Q2 2022 8.8m +477.8k +477,824 5.7%
21 AGIOS PHARMACEUTICALS INC COM AGIO AGIO 4,062,792 $90.1m1.27% 1.27% ReducedShares held: Q3 2021 4.3m, Q4 2021 4.3m, Q1 2022 4.1m, Q2 2022 4.1m -66.5k -66,500 -1.6%
22 ARVINAS INC COM ARVN ARVN 2,124,276 $89.4m1.26% 1.26% ReducedShares held: Q3 2021 2.2m, Q4 2021 2.2m, Q1 2022 2.2m, Q2 2022 2.1m -55.0k -54,977 -2.5%
23 FATE THERAPEUTICS INC COM FATE FATE 3,550,086 $88.0m1.24% 1.24% ReducedShares held: Q3 2021 3.2m, Q4 2021 3.8m, Q1 2022 3.6m, Q2 2022 3.6m -26.4k -26,400 -0.7%
24 SAREPTA THERAPEUTICS INC COM SRPT SRPT 1,139,455 $85.4m1.21% 1.21% ReducedShares held: Q3 2021 569.2k, Q4 2021 826.7k, Q1 2022 1.2m, Q2 2022 1.1m -11.7k -11,704 -1.0%
25 BECTON DICKINSON & CO COM BDX BDX 342,982 $84.6m1.20% 1.20% ReducedShares held: Q3 2021 455.6k, Q4 2021 455.4k, Q1 2022 396.4k, Q2 2022 343.0k -53.4k -53,423 -13.5%
26 INSULET CORP COM PODD PODD 386,335 $84.2m1.19% 1.19% ReducedShares held: Q3 2021 383.0k, Q4 2021 382.7k, Q1 2022 398.2k, Q2 2022 386.3k -11.9k -11,854 -3.0%
27 OPTION CARE HEALTH INC COM NEW OPCH OPCH 2,887,259 $80.2m1.13% 1.13% ReducedShares held: Q3 2021 2.6m, Q4 2021 2.9m, Q1 2022 3.2m, Q2 2022 2.9m -345.5k -345,528 -10.7%
28 TANDEM DIABETES CARE INC COM NEW TNDM TNDM 1,315,873 $77.9m1.10% 1.10% AddedShares held: Q3 2021 1.0m, Q4 2021 949.3k, Q1 2022 1.1m, Q2 2022 1.3m +199.4k +199,365 17.9%
29 INSPIRE MED SYS INC COM INSP INSP 407,057 $74.4m1.05% 1.05% AddedShares held: Q3 2021 421.1k, Q4 2021 420.8k, Q1 2022 397.5k, Q2 2022 407.1k +9.6k +9,551 2.4%
30 MYOVANT SCIENCES LTD COM MYOV MYOV 5,919,639 $73.6m1.04% 1.04% AddedShares held: Q3 2021 5.8m, Q4 2021 6.2m, Q1 2022 5.9m, Q2 2022 5.9m +60.6k +60,600 1.0%
31 INSMED INC COM PAR $.01 INSM INSM 3,621,562 $71.4m1.01% 1.01% AddedShares held: Q3 2021 3.4m, Q4 2021 3.5m, Q1 2022 3.6m, Q2 2022 3.6m +69.8k +69,786 2.0%
32 SHOCKWAVE MED INC COM SWAV SWAV 370,699 $70.9m1.00% 1.00% ReducedShares held: Q3 2021 464.2k, Q4 2021 426.6k, Q1 2022 398.6k, Q2 2022 370.7k -27.9k -27,878 -7.0%
33 MOLINA HEALTHCARE INC COM MOH MOH 248,313 $69.4m0.98% 0.98% ReducedShares held: Q3 2021 168.3k, Q4 2021 314.6k, Q1 2022 302.8k, Q2 2022 248.3k -54.5k -54,484 -18.0%
34 DEXCOM INC COM DXCM DXCM 928,508 $69.2m0.98% 0.98% ReducedShares held: Q3 2021 1.1m, Q4 2021 940.6k, Q1 2022 939.6k, Q2 2022 928.5k -11.1k -11,092 -1.2%
35 HUMANA INC COM HUM HUM 145,309 $68.0m0.96% 0.96% ReducedShares held: Q3 2021 312.8k, Q4 2021 303.7k, Q1 2022 147.4k, Q2 2022 145.3k -2.1k -2,133 -1.4%
36 RELAY THERAPEUTICS INC COM RLAY RLAY 4,032,262 $67.5m0.95% 0.95% AddedShares held: Q3 2021 3.8m, Q4 2021 4.1m, Q1 2022 3.9m, Q2 2022 4.0m +113.3k +113,300 2.9%
37 REVOLUTION MEDICINES INC COM RVMD RVMD 3,383,262 $65.9m0.93% 0.93% AddedShares held: Q3 2021 3.5m, Q4 2021 3.5m, Q1 2022 3.3m, Q2 2022 3.4m +72.6k +72,600 2.2%
38 EVOLENT HEALTH INC CL A EVH EVH 2,018,521 $62.0m0.88% 0.88% ReducedShares held: Q3 2021 3.0m, Q4 2021 2.6m, Q1 2022 2.6m, Q2 2022 2.0m -593.7k -593,742 -22.7%
39 AMEDISYS INC COM AMED AMED 585,154 $61.5m0.87% 0.87% AddedShares held: Q3 2021 302.8k, Q4 2021 490.0k, Q1 2022 576.1k, Q2 2022 585.2k +9.0k +9,023 1.6%
40 MEDTRONIC PLC SHS MDT MDT 645,506 $57.9m0.82% 0.82% ReducedShares held: Q3 2021 339.1k, Q4 2021 667.4k, Q1 2022 656.0k, Q2 2022 645.5k -10.5k -10,524 -1.6%
41 CRISPR THERAPEUTICS AG NAMEN AKT CRSP CRSP 922,005 $56.0m0.79% 0.79% ReducedShares held: Q3 2021 974.7k, Q4 2021 974.7k, Q1 2022 926.9k, Q2 2022 922.0k -4.9k -4,900 -0.5%
42 EXELIXIS INC COM EXEL EXEL 2,678,500 $55.8m0.79% 0.79% ReducedShares held: Q3 2021 2.9m, Q4 2021 2.9m, Q1 2022 2.7m, Q2 2022 2.7m -40.5k -40,500 -1.5%
43 APELLIS PHARMACEUTICALS INC COM APLS APLS 1,206,422 $54.6m0.77% 0.77% AddedShares held: Q3 2021 48.0k, Q4 2021 650.6k, Q1 2022 1.1m, Q2 2022 1.2m +107.7k +107,710 9.8%
44 CAREDX INC COM CDNA CDNA 2,537,524 $54.5m0.77% 0.77% AddedShares held: Q3 2021 30.9k, Q4 2021 1.5m, Q1 2022 2.3m, Q2 2022 2.5m +226.3k +226,348 9.8%
45 THE CIGNA GROUP COM CI CI 193,657 $51.0m0.72% 0.72% ReducedShares held: Q3 2021 217.8k, Q4 2021 245.2k, Q1 2022 259.1k, Q2 2022 193.7k -65.5k -65,489 -25.3%
46 CHARLES RIV LABS INTL INC COM CRL CRL 231,069 $49.4m0.70% 0.70% AddedShares held: Q3 2021 63.3k, Q4 2021 65.9k, Q1 2022 126.4k, Q2 2022 231.1k +104.7k +104,663 82.8%
47 HCA HEALTHCARE INC COM HCA HCA 292,771 $49.2m0.70% 0.70% ReducedShares held: Q3 2021 341.5k, Q4 2021 294.4k, Q1 2022 300.2k, Q2 2022 292.8k -7.4k -7,426 -2.5%
48 OMNICELL COM COM OMCL OMCL 425,823 $48.4m0.68% 0.68% AddedShares held: Q3 2021 393.6k, Q4 2021 362.3k, Q1 2022 362.3k, Q2 2022 425.8k +63.5k +63,491 17.5%
49 CENTENE CORP DEL COM CNC CNC 545,903 $46.2m0.65% 0.65% ReducedShares held: Q3 2021 1.2m, Q4 2021 660.0k, Q1 2022 660.6k, Q2 2022 545.9k -114.7k -114,732 -17.4%
50 BIO RAD LABS INC CL A BIO BIO 91,161 $45.1m0.64% 0.64% AddedShares held: Q3 2021 46.0k, Q4 2021 39.7k, Q1 2022 72.0k, Q2 2022 91.2k +19.2k +19,152 26.6%
51 PFIZER INC COM PFE PFE 835,684 $43.8m0.62% 0.62% AddedShares held: Q3 2021 99.6k, Q4 2021 113.0k, Q1 2022 46.5k, Q2 2022 835.7k +789.2k +789,184 1697.2%
52 HALOZYME THERAPEUTICS INC COM HALO HALO 971,300 $42.7m0.60% 0.60% ReducedShares held: Q3 2021 921.5k, Q4 2021 1.1m, Q1 2022 1.0m, Q2 2022 971.3k -52.9k -52,900 -5.2%
53 ABIOMED INC COM ABMD ABMD 169,509 $42.0m0.59% 0.59% AddedShares held: Q3 2021 151.2k, Q4 2021 150.2k, Q1 2022 150.2k, Q2 2022 169.5k +19.3k +19,331 12.9%
54 IDEXX LABS INC COM IDXX IDXX 115,773 $40.6m0.57% 0.57% ReducedShares held: Q3 2021 118.1k, Q4 2021 118.0k, Q1 2022 117.8k, Q2 2022 115.8k -2.0k -2,037 -1.7%
55 THERMO FISHER SCIENTIFIC INC COM TMO TMO 71,818 $39.0m0.55% 0.55% ReducedShares held: Q3 2021 86.9k, Q4 2021 98.3k, Q1 2022 72.6k, Q2 2022 71.8k -815 -815 -1.1%
56 SILK RD MED INC COM SILK SILK 1,047,286 $38.1m0.54% 0.54% AddedShares held: Q3 2021 781.7k, Q4 2021 952.4k, Q1 2022 1.0m, Q2 2022 1.0m +1.7k +1,719 0.2%
57 GLOBUS MED INC CL A GMED GMED 656,681 $36.9m0.52% 0.52% ReducedShares held: Q3 2021 729.4k, Q4 2021 757.5k, Q1 2022 745.3k, Q2 2022 656.7k -88.6k -88,573 -11.9%
58 IQVIA HLDGS INC COM IQV IQV 168,598 $36.6m0.52% 0.52% AddedShares held: Q3 2021 190.6k, Q4 2021 163.5k, Q1 2022 159.1k, Q2 2022 168.6k +9.5k +9,478 6.0%
59 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 630,439 $34.7m0.49% 0.49% ReducedShares held: Q3 2021 286.6k, Q4 2021 657.7k, Q1 2022 660.1k, Q2 2022 630.4k -29.6k -29,630 -4.5%
60 OUTSET MED INC COM OM OM 2,326,718 $34.6m0.49% 0.49% AddedShares held: Q3 2021 457.1k, Q4 2021 560.6k, Q1 2022 2.0m, Q2 2022 2.3m +309.6k +309,559 15.3%
61 HARMONY BIOSCIENCES HLDGS IN COM HRMY HRMY 702,068 $34.2m0.48% 0.48% AddedShares held: Q3 2021 129.3k, Q4 2021 121.2k, Q1 2022 125.0k, Q2 2022 702.1k +577.1k +577,107 461.8%
62 VEEVA SYS INC CL A COM VEEV VEEV 168,776 $33.4m0.47% 0.47% AddedShares held: Q3 2021 174.6k, Q4 2021 165.0k, Q1 2022 160.6k, Q2 2022 168.8k +8.2k +8,175 5.1%
63 ALIGN TECHNOLOGY INC COM ALGN ALGN 135,240 $32.0m0.45% 0.45% ReducedShares held: Q3 2021 157.0k, Q4 2021 146.6k, Q1 2022 141.4k, Q2 2022 135.2k -6.1k -6,111 -4.3%
64 AXSOME THERAPEUTICS INC COM AXSM AXSM 817,141 $31.3m0.44% 0.44% AddedShares held: Q3 2021 752.9k, Q4 2021 651.9k, Q1 2022 719.5k, Q2 2022 817.1k +97.7k +97,659 13.6%
65 EXACT SCIENCES CORP COM EXAS EXAS 758,023 $29.9m0.42% 0.42% AddedShares held: Q3 2021 429.3k, Q4 2021 642.6k, Q1 2022 719.3k, Q2 2022 758.0k +38.7k +38,720 5.4%
66 BAXTER INTL INC COM BAX BAX 457,819 $29.4m0.42% 0.42% ReducedShares held: Q3 2021 923.2k, Q4 2021 449.8k, Q1 2022 489.9k, Q2 2022 457.8k -32.1k -32,061 -6.5%
67 ADAPTIVE BIOTECHNOLOGIES COR COM ADPT ADPT 3,539,055 $28.6m0.40% 0.40% AddedShares held: Q3 2021 1.3m, Q4 2021 2.0m, Q1 2022 3.1m, Q2 2022 3.5m +393.8k +393,762 12.5%
68 ZIMMER BIOMET HOLDINGS INC COM ZBH ZBH 266,087 $28.0m0.40% 0.40% ReducedShares held: Q3 2021 280.1k, Q4 2021 271.2k, Q1 2022 270.7k, Q2 2022 266.1k -4.6k -4,647 -1.7%
69 ESPERION THERAPEUTICS INC NE COM ESPR ESPR 4,235,264 $26.9m0.38% 0.38% ReducedShares held: Q3 2021 4.5m, Q4 2021 4.5m, Q1 2022 4.3m, Q2 2022 4.2m -63.9k -63,900 -1.5%
70 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 337,434 $26.9m0.38% 0.38% ReducedShares held: Q3 2021 416.2k, Q4 2021 368.6k, Q1 2022 345.1k, Q2 2022 337.4k -7.7k -7,666 -2.2%
71 ACCOLADE INC COM ACCD ACCD 3,634,886 $26.9m0.38% 0.38% AddedShares held: Q3 2021 1.9m, Q4 2021 2.7m, Q1 2022 3.4m, Q2 2022 3.6m +253.4k +253,379 7.5%
72 AURINIA PHARMACEUTICALS INC COM AUPH AUPH 2,671,413 $26.8m0.38% 0.38% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 2.4m, Q2 2022 2.7m +265.6k +265,588 11.0%
73 PACIFIC BIOSCIENCES CALIF IN COM PACB PACB 5,961,229 $26.3m0.37% 0.37% AddedShares held: Q3 2021 1.6m, Q4 2021 1.6m, Q1 2022 4.9m, Q2 2022 6.0m +1.1m +1,079,477 22.1%
74 ATRICURE INC COM ATRC ATRC 641,896 $26.2m0.37% 0.37% AddedShares held: Q3 2021 418.0k, Q4 2021 498.6k, Q1 2022 598.6k, Q2 2022 641.9k +43.3k +43,291 7.2%
75 COOPER COS INC COM NEW COM NEW 81,479 $25.5m0.36% 0.36% ReducedShares held: Q3 2021 74.3k, Q4 2021 83.3k, Q1 2022 83.2k, Q2 2022 81.5k -1.7k -1,737 -2.1%
76 KEZAR LIFE SCIENCES INC COM COM 3,035,000 $25.1m0.35% 0.35% ReducedShares held: Q3 2021 4.5m, Q4 2021 4.9m, Q1 2022 4.7m, Q2 2022 3.0m -1.6m -1,633,148 -35.0%
77 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 925,000 $24.9m0.35% 0.35% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 925.0k
78 PENUMBRA INC COM PEN PEN 192,588 $24.0m0.34% 0.34% ReducedShares held: Q3 2021 205.7k, Q4 2021 193.7k, Q1 2022 193.7k, Q2 2022 192.6k -1.1k -1,066 -0.6%
79 GENERATION BIO CO COM COM 3,627,280 $23.8m0.34% 0.34% ReducedShares held: Q3 2021 2.5m, Q4 2021 3.9m, Q1 2022 3.7m, Q2 2022 3.6m -54.9k -54,900 -1.5%
80 TELEFLEX INCORPORATED COM TFX TFX 95,984 $23.6m0.33% 0.33% ReducedShares held: Q3 2021 97.8k, Q4 2021 97.8k, Q1 2022 97.7k, Q2 2022 96.0k -1.7k -1,730 -1.8%
81 BIONTECH SE SPONSORED ADS BNTX BNTX 151,200 $22.5m0.32% 0.32% AddedShares held: Q3 2021 12.7k, Q4 2021 113.5k, Q1 2022 111.8k, Q2 2022 151.2k +39.4k +39,434 35.3%
82 BEAM THERAPEUTICS INC COM BEAM BEAM 572,621 $22.2m0.31% 0.31% ReducedShares held: Q3 2021 612.8k, Q4 2021 612.8k, Q1 2022 582.8k, Q2 2022 572.6k -10.2k -10,200 -1.8%
83 MACROGENICS INC COM MGNX MGNX 7,325,514 $21.6m0.31% 0.31% UnchangedShares held: Q3 2021 8.5m, Q4 2021 8.6m, Q1 2022 7.3m, Q2 2022 7.3m
84 HUTCHMED CHINA LTD SPONSORED ADS HCM HCM 1,756,307 $21.4m0.30% 0.30% AddedShares held: Q3 2021 1.0m, Q4 2021 1.1m, Q1 2022 1.8m, Q2 2022 1.8m +5.6k +5,617 0.3%
85 CVS HEALTH CORP COM CVS CVS 229,153 $21.2m0.30% 0.30% ReducedShares held: Q3 2021 158.5k, Q4 2021 228.8k, Q1 2022 232.4k, Q2 2022 229.2k -3.2k -3,202 -1.4%
86 CASTLE BIOSCIENCES INC COM CSTL CSTL 941,059 $20.7m0.29% 0.29% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 607.6k, Q2 2022 941.1k +333.4k +333,445 54.9%
87 PROCEPT BIOROBOTICS CORP COM PRCT PRCT 595,380 $19.5m0.28% 0.28% AddedShares held: Q3 2021 150.0k, Q4 2021 173.6k, Q1 2022 286.1k, Q2 2022 595.4k +309.3k +309,305 108.1%
88 HOLOGIC INC COM HOLX HOLX 270,825 $18.8m0.27% 0.27% ReducedShares held: Q3 2021 870.7k, Q4 2021 579.4k, Q1 2022 275.8k, Q2 2022 270.8k -5.0k -4,958 -1.8%
89 TRANSMEDICS GROUP INC COM TMDX TMDX 579,887 $18.2m0.26% 0.26% ReducedShares held: Q3 2021 581.0k, Q4 2021 581.0k, Q1 2022 581.0k, Q2 2022 579.9k -1.1k -1,142 -0.2%
90 MERSANA THERAPEUTICS INC COM COM 3,895,200 $18.0m0.25% 0.25% ReducedShares held: Q3 2021 4.3m, Q4 2021 4.2m, Q1 2022 4.0m, Q2 2022 3.9m -58.8k -58,800 -1.5%
91 RESMED INC COM RMD RMD 84,865 $17.8m0.25% 0.25% ReducedShares held: Q3 2021 88.1k, Q4 2021 86.5k, Q1 2022 86.3k, Q2 2022 84.9k -1.5k -1,484 -1.7%
92 PHREESIA INC COM PHR PHR 680,153 $17.0m0.24% 0.24% AddedShares held: Q3 2021 622.5k, Q4 2021 592.3k, Q1 2022 580.5k, Q2 2022 680.2k +99.7k +99,655 17.2%
93 ILLUMINA INC COM ILMN ILMN 86,867 $16.0m0.23% 0.23% AddedShares held: Q3 2021 70.1k, Q4 2021 75.1k, Q1 2022 78.9k, Q2 2022 86.9k +8.0k +7,986 10.1%
94 ESSA PHARMA INC COM NEW EPI EPI 5,009,714 $15.8m0.22% 0.22% ReducedShares held: Q3 2021 5.0m, Q4 2021 5.0m, Q1 2022 5.0m, Q2 2022 5.0m -25.1k -25,100 -0.5%
95 AVANTOR INC COM AVTR AVTR 503,007 $15.6m0.22% 0.22% ReducedShares held: Q3 2021 512.2k, Q4 2021 512.2k, Q1 2022 512.2k, Q2 2022 503.0k -9.2k -9,209 -1.8%
96 PRIVIA HEALTH GROUP INC COM PRVA PRVA 519,876 $15.1m0.21% 0.21% ReducedShares held: Q3 2021 525.0k, Q4 2021 525.0k, Q1 2022 525.0k, Q2 2022 519.9k -5.1k -5,124 -1.0%
97 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 4,494,458 $14.6m0.21% 0.21% ReducedShares held: Q3 2021 2.6m, Q4 2021 4.6m, Q1 2022 4.6m, Q2 2022 4.5m -68.4k -68,400 -1.5%
98 TELADOC HEALTH INC COM TDOC TDOC 416,112 $13.8m0.20% 0.20% AddedShares held: Q3 2021 215.9k, Q4 2021 363.2k, Q1 2022 363.2k, Q2 2022 416.1k +52.9k +52,896 14.6%
99 AMGEN INC COM AMGN AMGN 50,959 $12.4m0.18% 0.18% ReducedShares held: Q3 2021 34.0k, Q4 2021 58.1k, Q1 2022 53.8k, Q2 2022 51.0k -2.8k -2,841 -5.3%
100 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 2,152,025 $11.8m0.17% 0.17% ReducedShares held: Q3 2021 2.3m, Q4 2021 2.3m, Q1 2022 2.2m, Q2 2022 2.2m -32.4k -32,400 -1.5%

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
DENTSPLY SIRONA INC XRAY XRAY 159,129 $7.8m159.1k shares
BIOHAVEN PHARMACTL HLDG CO L BHVN BHVN 39,207 $4.6m39.2k shares
BURNING ROCK BIOTECH LTD 438,869 $4.1m438.9k shares
KYMERA THERAPEUTICS INC KYMR KYMR 52,400 $2.2m52.4k shares
BLUEPRINT MEDICINES CORP BPMC BPMC 26,000 $1.7m26.0k shares
C4 THERAPEUTICS INC CCCC CCCC 54,500 $1.3m54.5k shares
MIRATI THERAPEUTICS INC MRTX MRTX 14,800 $1.2m14.8k shares
GENETRON HLDGS LTD 535,822 $1.2m535.8k shares
QUANTERIX CORP QTRX QTRX 35,704 $1.0m35.7k shares
IDEAYA BIOSCIENCES INC IDYA IDYA 46,200 $517.0k46.2k shares
TAIWAN SEMICONDUCTOR MFG LTD TSM TSM 619 $65.0k619 shares
UNITED MICROELECTRONICS CORP UMC UMC 2,698 $25.0k2.7k shares
NIO INC NIO NIO 1,093 $23.0k1.1k shares
PDD HOLDINGS INC PDD PDD 466 $19.0k466 shares
BILIBILI INC BILI BILI 744 $19.0k744 shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
VIRIDIAN THERAPEUTICS INC VRDN · 13G · filed 2026-05-15 VRDN 6.6%≈ $123.6m new 13G 2026-05-15
IMMUNOCORE HLDGS PLC IMCR · 13G · filed 2025-11-14 IMCR 5.6% new 13G 2025-11-14
JADE BIOSCIENCES INC JBIO · 13G · filed 2026-08-14 JBIO 5.0%≈ $67.9m -1.8 pts 13G 2026-08-14